CRISPR-Cas9 is programmable RNA-guided DNA endonuclease that provides a simple method for altering genomes, enabling countless applications in basic and biomedical research, agriculture, and medicine. Join Amit Choudhary from the Broad Institute of Harvard and MIT during this free interactive broadcast as he demonstrates how CRISPR-Cas9 is propelling the discovery and validation of small-molecule-based therapeutics and the development of next-generation therapeutic modalities.
What You Will Learn
- What are the different CRISPR-based technologies
- The need for precision control of CRISPR-based technologies and how to establish such controls
- How CRISPR-based technologies are propelling the development of contemporary and emerging therapeutic modalities